Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 18 studies | 43% ± 18% | |
oligodendrocyte | 15 studies | 45% ± 16% | |
oligodendrocyte precursor cell | 15 studies | 69% ± 18% | |
endothelial cell | 12 studies | 28% ± 13% | |
microglial cell | 9 studies | 25% ± 7% | |
GABAergic neuron | 7 studies | 35% ± 14% | |
macrophage | 6 studies | 24% ± 9% | |
T cell | 6 studies | 26% ± 7% | |
interneuron | 5 studies | 33% ± 15% | |
endothelial cell of lymphatic vessel | 5 studies | 39% ± 11% | |
cardiac muscle cell | 4 studies | 20% ± 4% | |
glutamatergic neuron | 4 studies | 37% ± 13% | |
dendritic cell | 4 studies | 21% ± 7% | |
B cell | 4 studies | 23% ± 7% | |
natural killer cell | 4 studies | 31% ± 5% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 61% ± 6% | |
retinal pigment epithelial cell | 3 studies | 25% ± 4% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 25% ± 9% | |
CD4-positive, alpha-beta T cell | 3 studies | 39% ± 5% | |
CD8-positive, alpha-beta T cell | 3 studies | 29% ± 4% | |
epithelial cell | 3 studies | 42% ± 23% | |
retinal rod cell | 3 studies | 27% ± 3% | |
fibroblast | 3 studies | 23% ± 5% | |
Schwann cell | 3 studies | 38% ± 20% | |
lymphocyte | 3 studies | 55% ± 17% | |
adipocyte | 3 studies | 17% ± 1% | |
mast cell | 3 studies | 21% ± 6% | |
regulatory T cell | 3 studies | 34% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5083.26 | 2642 / 2642 | 100% | 88.45 | 704 / 705 |
prostate | 100% | 2616.82 | 245 / 245 | 99% | 24.71 | 496 / 502 |
thymus | 100% | 3380.18 | 652 / 653 | 98% | 27.68 | 595 / 605 |
pancreas | 98% | 1472.02 | 322 / 328 | 96% | 14.64 | 170 / 178 |
skin | 99% | 2056.72 | 1795 / 1809 | 94% | 48.82 | 443 / 472 |
kidney | 99% | 1696.40 | 88 / 89 | 93% | 19.43 | 838 / 901 |
esophagus | 100% | 3583.46 | 1445 / 1445 | 91% | 15.08 | 166 / 183 |
lung | 100% | 2771.49 | 576 / 578 | 89% | 12.50 | 1031 / 1155 |
liver | 99% | 1936.01 | 223 / 226 | 89% | 17.18 | 360 / 406 |
breast | 100% | 2325.98 | 458 / 459 | 86% | 11.71 | 961 / 1118 |
bladder | 100% | 2479.48 | 21 / 21 | 85% | 13.15 | 428 / 504 |
ovary | 100% | 3153.51 | 180 / 180 | 83% | 10.30 | 357 / 430 |
uterus | 100% | 2459.56 | 170 / 170 | 80% | 12.27 | 369 / 459 |
adrenal gland | 96% | 1427.11 | 248 / 258 | 83% | 11.83 | 191 / 230 |
stomach | 100% | 2372.25 | 359 / 359 | 78% | 10.41 | 223 / 286 |
intestine | 100% | 2970.13 | 966 / 966 | 69% | 7.91 | 362 / 527 |
blood vessel | 100% | 3371.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 4905.39 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2901.57 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 2820.59 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2237.69 | 906 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 3080.20 | 832 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 15.59 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 21.55 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 59% | 8.50 | 47 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000233 | Biological process | negative regulation of rRNA processing |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0045995 | Biological process | regulation of embryonic development |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0007507 | Biological process | heart development |
GO_0000432 | Biological process | positive regulation of transcription from RNA polymerase II promoter by glucose |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
GO_0090043 | Biological process | regulation of tubulin deacetylation |
GO_0006282 | Biological process | regulation of DNA repair |
GO_0060173 | Biological process | limb development |
GO_0018393 | Biological process | internal peptidyl-lysine acetylation |
GO_0071374 | Biological process | cellular response to parathyroid hormone stimulus |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0018394 | Biological process | peptidyl-lysine acetylation |
GO_0051302 | Biological process | regulation of cell division |
GO_0045722 | Biological process | positive regulation of gluconeogenesis |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0046600 | Biological process | negative regulation of centriole replication |
GO_0006094 | Biological process | gluconeogenesis |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0007613 | Biological process | memory |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_1902425 | Biological process | positive regulation of attachment of mitotic spindle microtubules to kinetochore |
GO_0018076 | Biological process | N-terminal peptidyl-lysine acetylation |
GO_0010835 | Biological process | regulation of protein ADP-ribosylation |
GO_0042311 | Biological process | vasodilation |
GO_0006473 | Biological process | protein acetylation |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0048511 | Biological process | rhythmic process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005813 | Cellular component | centrosome |
GO_0000776 | Cellular component | kinetochore |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031674 | Cellular component | I band |
GO_0005829 | Cellular component | cytosol |
GO_0031672 | Cellular component | A band |
GO_0140672 | Cellular component | ATAC complex |
GO_0000124 | Cellular component | SAGA complex |
GO_0042641 | Cellular component | actomyosin |
GO_0005634 | Cellular component | nucleus |
GO_0004145 | Molecular function | diamine N-acetyltransferase activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0004468 | Molecular function | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO_0061733 | Molecular function | peptide-lysine-N-acetyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0010484 | Molecular function | histone H3 acetyltransferase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0016407 | Molecular function | acetyltransferase activity |
GO_0035035 | Molecular function | histone acetyltransferase binding |
GO_0043992 | Molecular function | histone H3K9 acetyltransferase activity |
GO_0004402 | Molecular function | histone acetyltransferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0004861 | Molecular function | cyclin-dependent protein serine/threonine kinase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | KAT2B |
Protein name | Histone acetyltransferase KAT2B (EC 2.3.1.48) (Histone acetyltransferase PCAF) (Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor) (P/CAF) (Spermidine acetyltransferase KAT2B) (EC 2.3.1.57) |
Synonyms | PCAF |
Description | FUNCTION: Functions as a histone acetyltransferase (HAT) to promote transcriptional activation . Has significant histone acetyltransferase activity with core histones (H3 and H4), and also with nucleosome core particles . Has a a strong preference for acetylation of H3 at 'Lys-9' (H3K9ac) . Also acetylates non-histone proteins, such as ACLY, MAPRE1/EB1, PLK4, RRP9/U3-55K and TBX5 . Inhibits cell-cycle progression and counteracts the mitogenic activity of the adenoviral oncoprotein E1A . Acts as a circadian transcriptional coactivator which enhances the activity of the circadian transcriptional activators: NPAS2-BMAL1 and CLOCK-BMAL1 heterodimers . Involved in heart and limb development by mediating acetylation of TBX5, acetylation regulating nucleocytoplasmic shuttling of TBX5 . Acts as a negative regulator of centrosome amplification by mediating acetylation of PLK4 . Acetylates RRP9/U3-55K, a core subunit of the U3 snoRNP complex, impairing pre-rRNA processing . Acetylates MAPRE1/EB1, promoting dynamic kinetochore-microtubule interactions in early mitosis . Also acetylates spermidine . .; FUNCTION: (Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. . |
Accessions | ENST00000263754.5 Q92831 |